用米罗加巴林增强杜洛西丁,用于治疗晚期肺癌中塔干诱导的外周神经病变
Yasuhiro Nakajima1,2, Kozo Kuribayashi1, Akio Tada1,2
1Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Japan.
Cancer control : journal of the Moffitt Cancer Center
|June 25, 2025
概括
在晚期肺癌患者中,米罗加巴林添加到杜洛西丁显著降低了化疗诱导的周围神经病变 (CIPN) 疼痛. 这种组合为管理与纳税相关的神经损伤提供了有希望的方法.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 针对晚期肺癌的taxane化疗经常导致化疗诱导的周围神经病变 (CIPN).
- CIPN可能导致剂量减少,影响治疗疗效,并且缺乏已确定的治疗方法.
- 杜洛西丁是一种常见的辅助疗法,但它对严重的CIPN的有效性有限.
研究的目的:
- 评估米罗加巴林作为高级肺癌患者CIPN的补充治疗的疗效.
- 评估单独使用杜洛西丁治疗不充分的患者的疼痛减轻效果.
主要方法:
- 进行了一项回顾性观察性队列研究.
- 14名接受TAXAN化疗和杜洛西丁治疗的晚期肺癌患者接受了额外的米罗加巴林治疗.
- 使用数值评分表 (NRS) 评估疼痛,并通过Wilcoxon的签名等级和值测试进行统计分析.
主要成果:
- 在米罗加巴林给药后,NRS疼痛评分的中位数显著下降,从5.5降至4.0 (P = 0.041).
- 米罗加巴林在统计学上显著地减少了与CIPN相关的疼痛.
结论:
- 将米罗加巴林添加到杜洛西丁是一种有前途的策略,用于缓解高发性肺癌患者的CIPN.
- 这些发现支持进一步的临床研究和潜在的整合到CIPN管理的实践中.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
371
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
371
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
267
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
267


